Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorLouisiana State University Health Sciences Center in New Orleans

About this trial

The Impact of Health Literacy on the Attitudes toward Pharmacological Treatment in Patients with Schizophrenia Spectrum Disorder

This interventional study is aimed at:

* assessing and improving the health literacy and * assessing the attitude towards treatment of patients with schizophrenia spectrum disorders while they are admitted to the inpatient psychiatric unit.

Eligibility criteria

Qualifiers

Patients admitted to the University Medical Center-New Orleans (UMCNO) inpatient behavioral health unit ages 18 and older with a new or previous diagnosis of schizophrenia spectrum disorder outside of substance use disorders

Patients must be proficient in English.

Patients must have a government issued social security number (required for reimbursement through the university).

Disqualifiers

Patients at UMCNO that are ages 17 or younger

Patients with SSD and concomitant intellectual disability, as evidenced by prior documented history on chart review or patients suspected to have intellectual disability or impairment based on clinical interactions

Patients with concomitant substance use and documentation of psychosis being resolved after a period of washout and without the use of psychotropic medications

Patients unable to complete health literacy assessments, attitude towards treatment assessments, and IQ testing due to severity of symptoms during hospitalization

Trial design

Treatments tested in this trial

  • Educational sessions

Treatment groups

34 Participants
are divided into 1 treatment group

Sponsors and collaborators